It seems tortuous. The entry of T cells into muscle after exercise is almost certainly just a non-specific upgrade in traffic as for monocytes due...
Muscles normally fill up with T cells after at least unaccustomed exercise. If you were short on T regs there would probably be more pain and...
So it's OK after all to pick and choose? Has it not occurred to them that next time any regulatory body with patient representatives sits down to...
Is the conclusion that if studies selected on the basis of PEM failed to show any reliable evidence of effect and effect is not dependent on...
Paul Garner seems to have gone the full distance into quackery. Even some of the other BPS people ought to find this embarrassing. How you square...
Or being prepared to say anything to get out!
This sounds like a paradigm from the 1960s. Whether t has any value or not I don't know, but not much of a shift.
Paul Morgan is a world class immunologist with a special interest in complement. There might be recruitment problems for a study of this sort but...
But isn't that sort of the point? There are lots of things I only came to know about because of billboards.
It looks a good poster. It is hard to know what clinical trials to invest in with so little to go on but this puts it bluntly and may make a few...
This I see as the key problem here. I suspect most people can tell if they are taking 30mg of amitriptyline. It also highlights the problems of...
sorry, the predictive text changed 'anything' or maybe '.nything'
I agree that anything might cause ME but if we are going to discuss brain cell function it would be good to get it roughly right. 2 million...
The idea was a 'glial cell reaching into different parts of the brain'. There aren't any. As Trish says, we would do better to stick to science....
I think it must be nonsense because individual glia do not extend beyond a millimetre. It is the neurons that have connections over metres.
I don't think we know that cyclophosphamide did anything, since we do not have a randomised double blind trial. Even if it did something it need...
This looks like total pseudoscience from my perspective as the person who invented this as a treatment for autoimmunity. There is no good...
Except that the only difference in RoB2 is that it is less rigorous!
This looks like quite an important study. No surprise that RoB is useless but good to see it documented for therapy trials.
The new home for Cochrane in Norway is certainly called the Norwegian equivalent of that. I think sending a polite but disgruntled message to...
Separate names with a comma.
